BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30941972)

  • 1. Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.
    Xue T; Yang J; Song P; Zhou G
    J BUON; 2019; 24(1):215-220. PubMed ID: 30941972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-33 levels in patients with gastric cancer.
    Sun P; Ben Q; Tu S; Dong W; Qi X; Wu Y
    Dig Dis Sci; 2011 Dec; 56(12):3596-601. PubMed ID: 21643739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic role of serum interleukin-18 in gastric cancer patients.
    Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
    World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.
    Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C
    Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values of normal preoperative serum cancer markers for gastric cancer.
    Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H
    Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
    Yin LK; Sun XQ; Mou DZ
    Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
    BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer.
    Filella X; Fuster J; Molina R; Grau JJ; García-Valdecasas JC; Grande L; Estapé J; Ballesta AM
    Acta Oncol; 1994; 33(7):747-51. PubMed ID: 7993641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of gastric cancer with the Clinical Stage Prediction score.
    Taniguchi K; Ota M; Yamada T; Serizawa A; Noguchi T; Amano K; Kotake S; Ito S; Ikari N; Omori A; Yamamoto M
    World J Surg Oncol; 2019 Mar; 17(1):47. PubMed ID: 30849974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.
    Erturk K; Tastekin D; Serilmez M; Bilgin E; Bozbey HU; Vatansever S
    Tumour Biol; 2016 Jan; 37(1):405-12. PubMed ID: 26219901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
    Chen C; Chen Q; Zhao Q; Liu M; Guo J
    Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interleukin-6 levels reflect disease status of gastric cancer.
    Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW
    Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma.
    Liao WC; Lin JT; Wu CY; Huang SP; Lin MT; Wu AS; Huang YJ; Wu MS
    Clin Cancer Res; 2008 Jan; 14(2):428-34. PubMed ID: 18198221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum level of interleukin-35 as a potential prognostic factor for gastric cancer.
    Gu JH; Wang XG; Wang LQ; Zhou LN; Tang M; Li P; Wu XY; Chen MB; Zhang Y
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):52-59. PubMed ID: 33044052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Integration and analysis of associated data in surgical treatment of gastric cancer based on multicenter, high volume databases].
    Wang W; Sun Z; Deng J; Wang Z; Zhou Z; Liang H; Xu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Feb; 19(2):179-85. PubMed ID: 26831882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
    Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
    Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
    Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
    Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.